Low molecular weight heparin-induced hyperkalemia and hyponatremia. Report of one case

Low molecular weight heparin-induced hyperkalemia is not an uncommon side effect. The development of hyponatremia is well described although it is less common. We report a 72-year-old woman with lumbar metastases who developed hyponatremia and hyperkalemia on the tenth day of hospitalization. Hyponatremia, with limited criteria for syndrome of inappropriate secretion of antidiuretic hormone, did not resolve with vigorous volume restriction. Hyperkalemia without an acid-base disorder or baseline renal failure, did not resolve after losartan was stopped. Enoxaparin-induced hypoaldosteronism was proposed and the drug was discontinued. After four days' persistence of the electrolyte disturbance, dexamethasone was changed to Hydrocortisone, and parameters normalized in 24 hours. The patient remained well until discharge and during outpatient control.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:149

Enthalten in:

Revista medica de Chile - 149(2021), 2 vom: 29. Feb., Seite 291-294

Sprache:

Spanisch

Weiterer Titel:

Hiponatremia e hiperpotasemia persistente inducida por enoxaparina y revertida con hidrocortisona en paciente con metástasis lumbares

Beteiligte Personen:

Eymin, Gonzalo [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Heparin, Low-Molecular-Weight
Journal Article

Anmerkungen:

Date Completed 07.09.2021

Date Revised 07.09.2021

published: Print

Citation Status MEDLINE

doi:

10.4067/s0034-98872021000200291

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330217267